EGFR and non-small cell lung carcinoma: It has been reported that treatment of NSCLC lines with dasatinib results in apoptosis; however, apoptosis was reported in NSCLC cell lines with a MU EGFR phenotype, but not in cell lines with a WT EGFR phenotype [9].